Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Autoimmunity Reviews|April 7, 2007
Non-redundant peptidomes from DAPs: towards "the vaccine"?Darja Kanduc, Alberta Lucchese, Abraham MittelmanEuropean Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 7, 2003
Microarray analysis of diet-induced alterations in gene expression in the ACI rat prostateNiradiz Reyes, Michael Iatropoulos, Abraham Mittelman, et al.Journal of Experimental Therapeutics & Oncology|June 8, 2007
Degenerate binding of tyrosinase peptides to MHC II Ad/Ed moleculesAbraham Mittelman, Guglielmo Lucchese, Angela Stufano, et al.Current Pharmaceutical Biotechnology|February 10, 2009
Targeting the immune system in cancerDevyani Chaudhuri, Robert Suriano, Abraham Mittelman, et al.International Journal of Cancer|March 29, 2002
Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteomeAbraham Mittelman, Alberta Lucchese, Animesh A Sinha, et al.Experimental Dermatology|June 11, 2005
Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysisJörg Willers, Alberta Lucchese, Abraham Mittelman, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinityAlberta Lucchese, Jörg Willers, Abraham Mittelman, et al.The Prostate|October 16, 2004
Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesisIsmael Reyes, Niradiz Reyes, Michael Iatropoulos, et al.Peptides|October 27, 2004
Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicityRaj Tiwari, Jan Geliebter, Alberta Lucchese, et al.Peptides|April 2, 2003
Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitopeAlberta Lucchese, Stefan Stevanovic, Animesh A Sinha, et al.Pageof 4